Christopher Kerns
Dental Laboratory Technician Cynthiana, KY Doctor of Dentistry
NPI 1265726863 CMS profile 1348130
114 S Main St, Cynthiana, KY 41031
General payments
$573
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Christopher Kerns of Cynthiana, KY is reported in the CMS Open Payments database as having received $573 across 16 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $69 | 4 | |
| 2023 | General | $14 | 1 | |
| 2021 | General | $95 | 1 | |
| 2020 | General | $222 | 4 | |
| 2019 | General | $172 | 6 |
Beside peers
- Christopher Kerns
- Kentucky median
- Middle half of Kentucky
- National median
In program year 2025, general payments to Christopher Kerns were reported at $0. Among 16,442 Kentucky profiles paid that year, the median was $196 and the middle half received between $57 and $680.
Show as a table
| Year | Christopher Kerns | Kentucky median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $172 | $193 | $56–$693 | $163 |
| 2020 | $222 | $129 | $40–$417 | $114 |
| 2021 | $95 | $144 | $41–$495 | $132 |
| 2022 | $0 | $167 | $49–$565 | $149 |
| 2023 | $14 | $195 | $57–$629 | $160 |
| 2024 | $69 | $193 | $55–$669 | $164 |
| 2025 | $0 | $196 | $57–$680 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
56
Drug cost
$189
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin | Generic | 33 | $99 | |
| Chlorhexidine Gluconate | Generic | 23 | $90 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
16 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Dental Laboratory Technician in Kentucky
Practitioners in the same specialty and state, ranked by reported value.
All Dental Laboratory Technician
Everyone recorded under this specialty, nationwide.
Doctors in Kentucky
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.